Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab.

Visvanathan S, Baum P, Vinisko R, Schmid R, Flack M, Lalovic B, Kleiner O, Fuentes-Duculan J, Garcet S, Davis JW, Grebe KM, Fine JS, Padula SJ, Krueger JG.

J Allergy Clin Immunol. 2019 Jun;143(6):2158-2169. doi: 10.1016/j.jaci.2018.11.042. Epub 2018 Dec 20.

2.

Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study.

Visvanathan S, Baum P, Salas A, Vinisko R, Schmid R, Grebe KM, Davis JW, Wallace K, Böcher WO, Padula SJ, Fine JS, Panés J.

J Crohns Colitis. 2018 Nov 9;12(10):1170-1179. doi: 10.1093/ecco-jcc/jjy099.

3.

Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus.

Lu P, Fleischmann R, Curtis C, Ignatenko S, Clarke SH, Desai M, Wong SL, Grebe KM, Black K, Zeng J, Stolzenbach J, Medema JK.

Lupus. 2018 Feb;27(2):290-302. doi: 10.1177/0961203317719334. Epub 2017 Jul 10.

PMID:
28691866
4.

Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.

Hensley SE, Zanker D, Dolan BP, David A, Hickman HD, Embry AC, Skon CN, Grebe KM, Griffin TA, Chen W, Bennink JR, Yewdell JW.

J Immunol. 2010 Apr 15;184(8):4115-22. doi: 10.4049/jimmunol.0903003. Epub 2010 Mar 12.

5.

Cutting edge: Sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis.

Grebe KM, Takeda K, Hickman HD, Bailey AL, Embry AC, Bennink JR, Yewdell JW.

J Immunol. 2010 Jan 15;184(2):540-4. doi: 10.4049/jimmunol.0903395. Epub 2009 Dec 16. Erratum in: J Immunol. 2010 Mar 1;184(5):2736. Bailey, Adam M [corrected to Bailey, Adam L].

6.

Editorial: regulation of the regulator: sympathetic nervous system control of regulatory T cells.

Grebe KM.

J Leukoc Biol. 2009 Dec;86(6):1269-70. doi: 10.1189/jlb.0409249. No abstract available.

PMID:
19948519
7.

Sympathetic nervous system control of anti-influenza CD8+ T cell responses.

Grebe KM, Hickman HD, Irvine KR, Takeda K, Bennink JR, Yewdell JW.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5300-5. doi: 10.1073/pnas.0808851106. Epub 2009 Mar 13.

8.

Heterosubtypic immunity to influenza A virus: where do we stand?

Grebe KM, Yewdell JW, Bennink JR.

Microbes Infect. 2008 Jul;10(9):1024-9. doi: 10.1016/j.micinf.2008.07.002. Epub 2008 Jul 9. Review.

9.
10.

Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages.

Litherland SA, Xie TX, Grebe KM, Davoodi-Semiromi A, Elf J, Belkin NS, Moldawer LL, Clare-Salzler MJ.

J Autoimmun. 2005 Jun;24(4):297-310. Epub 2005 Mar 23.

11.

Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection.

Grebe KM, Clarke RL, Potter TA.

Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10410-5. Epub 2004 Jul 1.

12.

IL10 resistant PGS2 expression in at-risk/Type 1 diabetic human monocytes.

Litherland SA, Xie TX, Grebe KM, Li Y, Moldawer LL, Clare-Salzler MJ.

J Autoimmun. 2004 May;22(3):227-33.

PMID:
15041043
13.

Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset.

Litherland SA, She JX, Schatz D, Fuller K, Hutson AD, Peng RH, Li Y, Grebe KM, Whittaker DS, Bahjat K, Hopkins D, Fang Q, Spies PD, North K, Wasserfall C, Cook R, Dennis MA, Crockett S, Sleasman J, Kocher J, Muir A, Silverstein J, Atkinson M, Clare-Salzler MJ.

Pediatr Diabetes. 2003 Mar;4(1):10-8.

PMID:
14655518

Supplemental Content

Loading ...
Support Center